Trial Details
COMPLETEDBasic Information
| Clinical ID | c3458 |
|---|---|
| Identifier | NCT02031276 |
| Trial Title | Efficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: risankizumab IV|DRUG: risankizumab SC|DRUG: Placebo |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2014-02 |
|---|---|
| Primary Completion Date | 2015-12 |
| Completion Date | 2016-11 |